News
Boehringer Ingelheim has slipped another piece of its oncology R&D strategy into place, partnering with Tessellate Bio on a ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Discover outperforming stocks and invest smarter with ...
NEW YORK, NY / ACCESS Newswire / April 21, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. (NASDAQ:SANA) investment and want to learn about a potential recovery under the federal ...
17h
News-Medical.Net on MSNCN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platformCN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with ...
Story April 14 - Third Harmonic Bio: The California biotech has abandoned plans to take its chronic spontaneous urticaria drug into phase 2, instead preparing to sell the asset while liquidating ...
2-Year U.S. Treasury Note Continuous Contract $103.730-0.039-0.04% 5-Year U.S. Treasury Note Continuous Contract $108.367 0.109 0.10% 10-Year U.S. Treasury Note Continuous Contract $111.203 0.406 ...
NEW ORLEANS — Fifteen years after the Deepwater Horizon oil rig exploded off the Gulf Coast, killing 11 and sending 134 million gallons (507.2 million liters) of crude gushing into the ocean ...
2-Year U.S. Treasury Note Continuous Contract $103.625-0.145-0.14% 5-Year U.S. Treasury Note Continuous Contract $108.031-0.227-0.21% 10-Year U.S. Treasury Note Continuous Contract $110.578-0.219 ...
So without further ado, here are our top picks for the best oils for stretch marks. We’ve used the Bio-Oil Skincare Body Oil for several months and have noticed a significant improvement in the ...
The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...
The report values San Francisco-based Nektar at $17 billion thanks to its multi-billion dollar deal with Bristol-Myers Squibb in February, the largest single product deal in biotech history.
The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results